Maraviroc Solution
Brand names: Selzentry
Category: Antiviral
FDA status: To Be Discontinued · Last FDA update: Jan 20, 2026 · First posted: Jan 20, 2026 · 1 manufacturers, 1 listed presentations
As of Jan 20, 2026, the FDA lists Maraviroc Solution as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Selzentry, Solution, 20 mg/mL Oral Solution Kit | 230 mL Oral Solution per Bottle | 1 Bottle per Carton (NDC 49702-260-55) NDC 49702-260-55 |
ViiV Healthcare Company | Not specified | The anticipated date that GSK will cease distribution of the product is approximately August 1, 2026. |
Related medications in shortage
Other Antiviral medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Maraviroc Solution (FDA data as of Jan 20, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Maraviroc Solution. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/maraviroc-solution.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).